Andrew Piskadlo is CEO and President of Pioneering Deep Tech Institute and Director of EmberGraph Intel, PDTI's first sponsored portfolio company.

Engineer and analytical chemist (B.S. Physics & Chemistry, Westminster College; M.S. Mechanical Engineering, University of Utah, 2025; concentration in mechatronics and process design; ISO 9001:2015 Internal Auditor). Founded Utah Research Institute in 2022; the institute was renamed Pioneering Deep Tech Institute effective December 2025.

At URI he led the NPI program and developed a point-of-care urinary collagen IV / eGFR correlation methodology for early chronic kidney disease detection — manuscript currently in submission to *Kidney International Reports*. Drove process-discipline transformation: 25% → 90% first-pass yield, 86% defect reduction on a URI manufacturing program. Co-led the 109-part mechatronic prosthetic design transfer at URI with Dr. Nick Witham under SolidWorks ePDM configuration control. Authored federal grant proposals across NSF SBIR, NIH, NASA, and DoD pipelines.

Co-architect of EmberGraph Intel — empty repository to working production in six weeks at ~$200 in API costs; eight-person team including three PhDs, all pre-payroll through architecture. Math-based forensic graph analysis on public records.

Methodology and ongoing analysis at [substack.com/@andrewpiskadlo](https://substack.com/@andrewpiskadlo).